New radiation approach targets tough pancreatic tumors
NCT ID NCT03505229
First seen Jan 31, 2026 · Last updated May 16, 2026 · Updated 14 times
Summary
This study tests a high-precision radiation treatment called SBRT for people with high-risk localized pancreatic cancer. The main goal is to see if this treatment can stop the tumor from growing in the treated area for at least 12 months. The study involves 30 participants who have already received or plan to receive chemotherapy, and it will also track side effects and how well the tumor responds to treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH RISK LOCALISED PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Royal North Shore Hospital
St Leonards, New South Wales, 2065, Australia
Conditions
Explore the condition pages connected to this study.